Literature DB >> 2460558

Anti-idiotypic antibodies against UV-induced tumor-specific CTL clones. Preparation in syngeneic combination.

K Kuribayashi1, C Tanaka, Y Matsubayashi, T Masuda, H Udono, M Abe, E Nakayama, H Shiku.   

Abstract

In this study, we first established several CTL clones of (BALB/c x C57BL/6)F1 origin that were specific for either syngeneic UV female 1 or UV male 1 fibrosarcoma cell lines. All the CTL clones had Thy-1+ Lyt-2+ L3T4- phenotypes and showed Kd restriction when lysing the corresponding target cells. Sera obtained from syngeneic animals immunized with three CTL clones, 10B-5 for UV female 1, and CTL9 and CTL10 for UV male 1, showed specific inhibition of target cell lysis with the corresponding CTL clones. The inhibitory activities were found in sera of the majority of immunized animals. Because the inhibitory activity resides in protein A-binding fraction, mAb were produced by hybridizing spleen cells of hyperimmune animals. N1-56 was thus obtained from a mouse immunized with 10B-5 CTL clone reactive with UV female 1. N1-56 was clonotype specific, reacting with 10B-5 but not with other CTL lines or leukemia cell lines. No N1-56+ cells were detectable in thymocytes, lymph node cells, or spleen cells of either naive or UV female 1-immune CB6F1 mice. Immunoprecipitation showed that N1-56 reacts with 90,000 Mr molecules on 10B-5 CTL clone under nonreducing conditions and 45,000 Mr molecules under reducing conditions, indicating its reactivities with idiotypic determinants of TCR on the CTL clone. N1-56 inhibited lytic activity of 10B-5, but neither N1-56 nor alpha-10B-5 hyperimmune serum inhibited that of alpha-UV female 1 mixed lymphocyte tumor cell culture cells. N1-56 induced proliferation of 10B-5 without addition of Ag.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460558

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  A single retroviral gag precursor signal peptide recognized by FBL-3 tumor-specific cytotoxic T lymphocytes.

Authors:  T Kondo; H Uenishi; T Shimizu; T Hirama; M Iwashiro; K Kuribayashi; H Tamamura; N Fujii; R Fujisawa; M Miyazawa
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

2.  Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection.

Authors:  M Iwashiro; R J Messer; K E Peterson; I M Stromnes; T Sugie; K J Hasenkrug
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

3.  The roles of CD8+ and CD4+ cells in tumor rejection.

Authors:  H Udono; M Mieno; H Shiku; E Nakayama
Journal:  Jpn J Cancer Res       Date:  1989-07

4.  Interferon-gamma-producing tumor induces host tumor-specific T cell responses.

Authors:  Y Teramura; Y Watanabe; N Kan; T Masuda; K Kuribayashi
Journal:  Jpn J Cancer Res       Date:  1993-06

5.  Effect of accessory cells on stimulation of murine T-cell leukemia with antibodies to the CD3/T cell antigen receptor complex.

Authors:  R Suto; H Udono; A Yamamoto; H Shiku; E Nakayama
Journal:  Jpn J Cancer Res       Date:  1993-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.